Yuichi Ozawa
Overview
Explore the profile of Yuichi Ozawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
578
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogasawara T, Hiraoka Y, Hosoya N, Sugiura M, Kishimoto E, Nagasaki K, et al.
Clin Nutr ESPEN
. 2025 Jan;
66:221-225.
PMID: 39884576
Background & Aims: To prevent food aspiration, numerous patients with aspiration pneumonia are restricted from eating early during their hospital stay. Although they receive parenteral nutrition (PN) on a fasting...
2.
Hiraoka Y, Ogasawara T, Tajima Y, Yaguchi T, Watanabe A, Teruya K, et al.
J Infect Chemother
. 2025 Jan;
31(3):102609.
PMID: 39793855
We describe a rare case of spontaneous remission of Pneumocystis jirovecii pneumonia (PCP) in a 42-year-old patient with human immunodeficiency virus (HIV) infection, followed by severe pulmonary nocardiosis. To our...
3.
Ozawa Y, Koh Y, Shibaki R, Harutani Y, Akamatsu H, Hayata A, et al.
Cancer Immunol Immunother
. 2024 Nov;
74(1):7.
PMID: 39487921
Objectives: The impact of cGAS/STING tumor expression on PD-1/L1 inhibitor efficacy and the tumor microenvironment remain to be elucidated. Methods: In a post-hoc analysis of a prospective biomarker study with...
4.
Murakami E, Akamatsu H, Teraoka S, Takakura T, Takase E, Tanaka M, et al.
Cancer Med
. 2024 Mar;
13(4):e6839.
PMID: 38457231
Background: Mannitol is exclusively recommended in the National Comprehensive Cancer Network guidelines for diuresis in cisplatin (CDDP)-based chemotherapy. The utility of furosemide, a widely used and convenient diuretic, thus requires...
5.
Kanasaki H, Ozawa Y, Nakamura N, Nagasaki K, Matsuyama W, Akahori D, et al.
Anticancer Res
. 2024 Feb;
44(2):723-730.
PMID: 38307579
Background/aim: Detection of genetic abnormalities is crucial for selecting an appropriate therapy to effectively treat advanced non-small cell lung cancer (NSCLC). Multiplex genetic testing aids the selection of appropriate therapy...
6.
Ozawa Y, Koh Y, Hase T, Chibana K, Kaira K, Okishio K, et al.
Ther Adv Med Oncol
. 2024 Jan;
16:17588359231225046.
PMID: 38282663
Background: ALK-tyrosine kinase inhibitors (ALK-TKIs) are effective for treating non-small-cell lung cancer with gene rearrangement; however, resistance is inevitable. Brigatinib is a unique ALK-TKI that is effective against many resistance...
7.
Takase E, Akamatsu H, Teraoka S, Nakaguchi K, Tanaka M, Kaki T, et al.
J Pain Symptom Manage
. 2023 Nov;
67(3):204-211.e1.
PMID: 37992848
Context: The efficacy and tolerability of high-flow nasal cannula (HFNC) for relieving dyspnea in advanced cancer patients with limited prognosis requires elucidation. Objectives: The primary aim of this trial was...
8.
Rudin C, Liu S, Soo R, Lu S, Hong M, Lee J, et al.
J Clin Oncol
. 2023 Nov;
42(3):324-335.
PMID: 37976444
Purpose: The phase III SKYSCRAPER-02 study determined whether the benefits of atezolizumab plus carboplatin and etoposide (CE) could be enhanced by the addition of tiragolumab in untreated extensive-stage small-cell lung...
9.
Ogasawara T, Tajima Y, Nakamura N, Kanasaki H, Matsuyama W, Niwa M, et al.
Clin Nutr
. 2023 Sep;
42(10):2045-2050.
PMID: 37677909
Background & Aims: The efficacy of vitamin D supplementation in coronavirus disease 2019 (COVID-19) remains unclear. This study aimed to evaluate the effect of 1-hydroxy-vitamin D on the prevention of...
10.
Miura S, Koh Y, Azuma K, Yoshioka H, Koyama K, Teraoka S, et al.
BMC Cancer
. 2023 Jan;
23(1):6.
PMID: 36597021
Background: Conquering acquired resistance to osimertinib remains a major challenge in treating patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC). Thus, we aimed to determine the...